GardeninA appears to modulate oxidative stress and neuroinflammatory responses involving Nrf2 and NF-κB that are known to be associated with PD pathogenesis and are viable targets for therapeutic intervention62. This evidence concerns the gene NFKB1 and Parkinson disease.